1. Home
  2. SNSE vs AEI Comparison

SNSE vs AEI Comparison

Compare SNSE & AEI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • AEI
  • Stock Information
  • Founded
  • SNSE 2005
  • AEI 2014
  • Country
  • SNSE United States
  • AEI United States
  • Employees
  • SNSE N/A
  • AEI N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • AEI Building operators
  • Sector
  • SNSE Health Care
  • AEI Real Estate
  • Exchange
  • SNSE Nasdaq
  • AEI Nasdaq
  • Market Cap
  • SNSE 12.5M
  • AEI 12.0M
  • IPO Year
  • SNSE 2021
  • AEI N/A
  • Fundamental
  • Price
  • SNSE $0.53
  • AEI $0.82
  • Analyst Decision
  • SNSE Strong Buy
  • AEI
  • Analyst Count
  • SNSE 3
  • AEI 0
  • Target Price
  • SNSE $4.33
  • AEI N/A
  • AVG Volume (30 Days)
  • SNSE 769.5K
  • AEI 2.8M
  • Earning Date
  • SNSE 02-26-2025
  • AEI 11-14-2024
  • Dividend Yield
  • SNSE N/A
  • AEI N/A
  • EPS Growth
  • SNSE N/A
  • AEI N/A
  • EPS
  • SNSE N/A
  • AEI N/A
  • Revenue
  • SNSE N/A
  • AEI $13,191,488.00
  • Revenue This Year
  • SNSE N/A
  • AEI N/A
  • Revenue Next Year
  • SNSE N/A
  • AEI N/A
  • P/E Ratio
  • SNSE N/A
  • AEI N/A
  • Revenue Growth
  • SNSE N/A
  • AEI N/A
  • 52 Week Low
  • SNSE $0.38
  • AEI $0.46
  • 52 Week High
  • SNSE $1.94
  • AEI $2.61
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 56.84
  • AEI 40.86
  • Support Level
  • SNSE $0.47
  • AEI $0.83
  • Resistance Level
  • SNSE $0.55
  • AEI $0.92
  • Average True Range (ATR)
  • SNSE 0.05
  • AEI 0.27
  • MACD
  • SNSE 0.00
  • AEI -0.02
  • Stochastic Oscillator
  • SNSE 65.98
  • AEI 3.80

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

About AEI Alset Inc. (TX)

Alset Inc is a diversified holding company engaged through its subsidiaries in the development of EHome communities and other real estate, financial services, digital transformation technologies, biohealth activities, and consumer products with operations in the United States, Singapore, Hong Kong, Australia, and South Korea. The Company operates in four business segments: real estate, digital transformation technology, Biohealth, and other business activities, and it derives a majority of its revenue from the Real Estate segment.

Share on Social Networks: